BDBM37578 2-[1,3-benzodioxol-5-yl(mesyl)amino]-N-[2-[(3-chlorobenzyl)thio]ethyl]acetamide::2-[1,3-benzodioxol-5-yl(methylsulfonyl)amino]-N-[2-[(3-chlorophenyl)methylsulfanyl]ethyl]acetamide::2-[1,3-benzodioxol-5-yl(methylsulfonyl)amino]-N-[2-[(3-chlorophenyl)methylsulfanyl]ethyl]ethanamide::2-[1,3-benzodioxol-5-yl(methylsulfonyl)amino]-N-[2-[(3-chlorophenyl)methylthio]ethyl]acetamide::MLS000051376::N~2~-1,3-benzodioxol-5-yl-N~1~-{2-[(3-chlorobenzyl)thio]ethyl}-N~2~-(methylsulfonyl)glycinamide::SMR000079526::cid_2223195
SMILES CS(=O)(=O)N(CC(=O)NCCSCc1cccc(Cl)c1)c1ccc2OCOc2c1
InChI Key InChIKey=SUXCRSHRPGWQMJ-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37578
Affinity DataIC50: 8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
